Literature DB >> 19780580

Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification.

Hanne Christine Bertram1, Nina Eggers, Nanna Eller.   

Abstract

In the present study, the ability of (1)H nuclear magnetic resonance (NMR) for metabolic profiling of human saliva samples was investigated. High-resolution (1)H NMR spectra were obtained, and signals were assigned to various metabolites mainly representing small organic acids and amino acids. In addition, the use of human saliva for metabolomic studies was evaluated, and multivariate data analysis revealed that the 92 morning and night samples from 46 subjects could be discriminated with a predictability of 85%. The diurnal effect on the salivary metabolite profile were ascribed to changes in intensities of several metabolites including trimethylamine oxide (TMAO), choline, propionate, alanine, methanol, and N-acetyl groups. No effects of gender and body mass index (BMI) on the salivary metabolite profile were detected. The relationships between the salivary metabolome and glycated hemoglobin, systolic and diastolic blood pressure were investigated; however, no significant correlations could be established.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19780580     DOI: 10.1021/ac9020598

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  22 in total

1.  The human circadian metabolome.

Authors:  Robert Dallmann; Antoine U Viola; Leila Tarokh; Christian Cajochen; Steven A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-31       Impact factor: 11.205

2.  Salivary biomarkers of physical fatigue as markers of sleep deprivation.

Authors:  Darren J Michael; Bianca Valle; Jennifer Cox; John E Kalns; Donovan L Fogt
Journal:  J Clin Sleep Med       Date:  2013-12-15       Impact factor: 4.062

3.  Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra.

Authors:  Pascal Mercier; Michael J Lewis; David Chang; David Baker; David S Wishart
Journal:  J Biomol NMR       Date:  2011-03-01       Impact factor: 2.835

4.  Development of isotope labeling LC-MS for human salivary metabolomics and application to profiling metabolome changes associated with mild cognitive impairment.

Authors:  Jiamin Zheng; Roger A Dixon; Liang Li
Journal:  Anal Chem       Date:  2012-12-06       Impact factor: 6.986

Review 5.  Omics Profiling in Precision Oncology.

Authors:  Kun-Hsing Yu; Michael Snyder
Journal:  Mol Cell Proteomics       Date:  2016-04-20       Impact factor: 5.911

Review 6.  Review: toxicometabolomics.

Authors:  Mounir Bouhifd; Thomas Hartung; Helena T Hogberg; Andre Kleensang; Liang Zhao
Journal:  J Appl Toxicol       Date:  2013-05-30       Impact factor: 3.446

7.  Analyzing and mapping sweat metabolomics by high-resolution NMR spectroscopy.

Authors:  Viktor P Kutyshenko; Maxim Molchanov; Peter Beskaravayny; Vladimir N Uversky; Maria A Timchenko
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

8.  Urinary Profile of Endogenous Gamma-Hydroxybutyric Acid and its Biomarker Metabolites in Healthy Korean Females: Determination of Age-Dependent and Intra-Individual Variability and Identification of Metabolites Correlated With Gamma-Hydroxybutyric Acid.

Authors:  Suji Kim; Suein Choi; Min Seo Lee; Mingyu Kim; Maria Park; Sungpil Han; Seunghoon Han; Hye Suk Lee; Sooyeun Lee
Journal:  Front Pharmacol       Date:  2022-04-13       Impact factor: 5.988

9.  The future of NMR metabolomics in cancer therapy: towards personalizing treatment and developing targeted drugs?

Authors:  Marie S A Palmnas; Hans J Vogel
Journal:  Metabolites       Date:  2013-05-17

10.  The same microbiota and a potentially discriminant metabolome in the saliva of omnivore, ovo-lacto-vegetarian and Vegan individuals.

Authors:  Francesca De Filippis; Lucia Vannini; Antonietta La Storia; Luca Laghi; Paola Piombino; Giuseppina Stellato; Diana I Serrazanetti; Giorgia Gozzi; Silvia Turroni; Ilario Ferrocino; Camilla Lazzi; Raffaella Di Cagno; Marco Gobbetti; Danilo Ercolini
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.